Thyroid Nodules in Patients with Acromegaly: Frequency According to the ACR TI-RADS Classification and its Relationship with Disease Activity

Abstract

Purpose: In our study, we aimed to determine the frequency of thyroid nodules in patients with acromegaly according to the American College of Radiology (ACR) Thyroid Imaging, Reporting and Data System (TI-RADS) classification and its relationship with acromegaly disease activity.

Methods: A total of 56 patients with acromegaly and age, sex, and body mass index matched with 56 healthy control subjects were included in our study. Thyroid-stimulating hormone, free thyroxine, and anti-thyroperoxidase antibody levels of patients and control subjects were measured. In addition, patients and healthy controls were evaluated by ultrasonography to determine thyroid structure, thyroid volume, and thyroid nodules and to make ACR TI-RADS classification.

Results: Thyroid nodules were present in 31 (55.4%) of 56 patients in the acromegaly group and 20 (35.7%) of 56 subjects in the control group, and the frequency of thyroid nodules was significantly higher in the acromegaly group (p=0.038). The mean number of nodules in the acromegaly group and control group was 1.27±1.43 and 0.48±0.73, respectively, and the mean number of nodules was significantly higher in the acromegaly group (p=0.003). The number of patients with TI-RADS 1, TI-RADS 2, and TI-RADS 4 nodules in the acromegaly group was higher than the control group (p=0.026, p=0.049, p=0.007, respectively). No difference was found in terms of cytological findings between those who have undergone FNAB in the acromegaly group and control group.

Conclusion: In our study, we found that the frequency of thyroid nodules, the number of thyroid nodules, and the number of TI-RADS 1, TI-RADS 2, and TI-RADS 4 nodules increased in patients with acromegaly. There was no significant difference between acromegaly disease activity and thyroid nodule frequency, number of thyroid nodules, and TI-RADS classifications.

Key words

acromegaly - ACR TI-RADS - thyroid nodule - disease activity

Publication History

Received: 17 February 2021
Received: 16 April 2021

Accepted: 03 May 2021

Article published online:
23 August 2021

• References

• 1 Colao A, Ferone D, Marzullo P. et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004; 25: 102-152
• 2 Herrmann BL, Baumann H, Janssen OE. et al. Impact of disease activity on thyroid disease in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes 2004; 112: 225-230
• 3 Wolinski K, Czarnywojtek A, Ruchala M. Risk of nodular thyroid disease and thyroid cancer in patients with acromegaly—meta-analysis and systematic review. PLoS One 2014; 14: e88787
• 4 Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 1997; 46: 545-549
• 5 Rogozinski A, Furioso A, Glikman P. et al. Thyroid nodules in acromegaly. Arq Bras Endocrinol Metabol 2012; 56: 300-304
• 6 Tessler FN, Middleton WD, Grant EG. et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14: 587-595
• 7 Roger P, Taton M, van Sande J. et al. Mitogenic effects of thyrotropin and adenosine 3’5’-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 1988; 66: 1158-1165
• 8 Kimura T, Van Keymeulen A, Golstein J. et al. Regulation of thyroid cell proliferation by tsh and other factors: a critical evaluation of in vitro models. Endocr Rev 2001; 22: 631-656
• 9 Yashiro T, Ohba Y, Murakami H. et al. Expression of insulin-like growth factor receptors in primary human thyroid neoplasms. Acta Endocrinol 1989; 121: 112-120
• 10 Liu YJ, Qiang W, Shi J. et al. Expression and significance of IGF-1 and IGF-1R in thyroid nodules. Endocrine 2013; 44: 158-164
• 11 Xu D, Wu B, Li X. et al. Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas. BMC Endocr Disord 2019; 19: 94
• 12 Kan S, Kizilgul M, Celik B. et al. The effect of disease activity on thyroid nodules in patients with acromegaly. Endocr J 2019; 25: 301-307
• 13 Curtò L, Giovinazzo S, Alibrandi A. et al. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study. Eur J Endocrinol 2015; 172: 543-552
• 14 Renehan AG, Zwahlen M, Minder C. et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353
• 15 Terzolo M, Reimondo G, Berchialla P. et al. Acromegaly is associated with increased cancer risk: a survey in Italy. Endocr Relat Cancer 2017; 24: 495-504
• 16 Xu T, Wu Y, Wu RX. et al. Validation and comparison of three newly-released thyroid imaging reporting and data systems for cancer risk determination. Endocrine 2019; 64: 299-307
• 17 Ha EJ, Na DG, Baek JH. et al. US Fine-needle aspiration biopsy for thyroid malignancy: diagnostic performance of seven society guidelines applied to 2000 thyroid nodules. Radiology 2018; 287: 893-900
• 18 Grani G, Lamartina L, Ascoli V. et al. Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: toward the “right” TIRADS. J Clin Endocrinol Metab 2019; 104: 95-102